SEMSKYVU

Serial Number 98812010
730

Registration Progress

Application Filed
Oct 21, 2024
Under Examination
Jun 17, 2025
Approved for Publication
Apr 22, 2025
Published for Opposition
Apr 22, 2025
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Jun 17, 2026 344 days

Basic Information

Serial Number
98812010
Deadline
June 17, 2026
Description
Statement of Use or 2nd Extension Due
Filing Date
October 21, 2024
Published for Opposition
April 22, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Jun 25, 2025
Application
Pending
Classes
005

Rights Holder

Edgewise Therapeutics, Inc.

03
Address
1715 38th Street
Boulder, CO 80301

Ownership History

Edgewise Therapeutics, Inc.

Original Applicant
03
Boulder, CO

Edgewise Therapeutics, Inc.

Owner at Publication
03
Boulder, CO

Legal Representation

Attorney
Aaron D. Hendelman

USPTO Deadlines

Next Deadline
344 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
June 17, 2026
Extension Available
Until June 17, 2026

Application History

15 events
Date Code Type Description
Jun 26, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 25, 2025 EXT1 S SOU EXTENSION 1 FILED
Jun 25, 2025 EX1G S SOU EXTENSION 1 GRANTED
Jun 25, 2025 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 17, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 22, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 22, 2025 PUBO A PUBLISHED FOR OPPOSITION
Apr 16, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 3, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 3, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 3, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 27, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 25, 2025 DOCK D ASSIGNED TO EXAMINER
Oct 21, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of neuromuscular and cardiac disorders and diseases; anti-inflammatories

Classification

International Classes
005